The Food and Drug Administration (FDA) asked for rare disease stakeholders, including individuals and families affected by rare disease(s), pharmaceutical companies, trade associations, and other federal agencies and regulators, to weigh in on a proposed clinical...
COVID-19 has forced most of the world to work remotely, causing a major disruption in clinical research and the drug development process. As a result, the need for centralized and advanced patient engagement technology to better healthcare for all parties involved,...
BioNTech, and Pfizer have partnered to produce one of the 17 Covid vaccines currently in development. The vaccine has shown promising early-stage human trials among 24 participants, alongside other pharmaceutical companies like Moderna, Inovio Pharmaceuticals,...
